Microfluidic model of the blood brain barrier

Patent metadata

Field	Value
Publication number	US-12378519-B2
Application number	US-202318529198-A
Country	US
Kind code	B2
Filing date	Dec 5, 2023
Priority date	Oct 19, 2015
Publication date	Aug 5, 2025
Grant date	Aug 5, 2025

Abstract

The invention relates to culturing brain endothelial cells, and optionally astrocytes and neurons in a fluidic device under conditions whereby the cells mimic the structure and function of the blood brain barrier. Culture of such cells in a microfluidic device, whether alone or in combination with other cells, drives maturation and/or differentiation further than existing systems.

First claim

The invention claimed is:

1. A method of culturing cells, comprising:
a) providing a microfluidic device comprising a porous membrane, said membrane comprising a top surface and a bottom surface;
b) seeding brain microvascular endothelial cells on said bottom surface so as to create seeded-cells on said bottom surface of said membrane;
c) seeding stem cell-derived neuronal cells or neuronal cells differentiated from stem cells on said top surface to create seeded cells on said top surface of said membrane; and
d) culturing said top surface seeded cells under flow conditions that support the maturation of neurons and culturing said bottom surface seeded cells under conditions that support maturation of said brain microvascular endothelial cells wherein said neurons exhibit a more mature electrophysiology, in terms of one or more features selected from the group consisting of action potential patterns, negative sodium channel current, positive potassium channel current and action potential spikes of amplitude, duration and frequency, or increased frequency after exposure to said flow as compared to the same neurons cultured in a static culture.

2. The method of claim 1 , further comprising e) seeding astrocytes to create seeded astrocyte cells.

3. The method of claim 2 , further comprising culturing said astrocytes under conditions such that an astrocyte or portion thereof transmigrates said membrane and contacts one or more said brain microvascular endothelial cells on said bottom surface.

4. The method of claim 1 , wherein said stem cell-derived cells are derived or extracted from EZ spheres, iNPCs or iMNPs, and/or wherein said seeded cells in step c) are human cells.

5. A method of culturing cells, comprising:
a) providing a microfluidic device comprising a porous membrane, said membrane comprising a top surface and a bottom surface;
b) coating said top surface of said membrane with laminin and said bottom surface with a mixture of collagen and fibronectin, said mixture free of laminin;
c) seeding induced neural progenitor cells on said top surface and brain microvascular endothelial cells on said bottom surface so as to create seeded cells;
d) exposing said seeded cells to a flow of culture media; and
e) culturing said seeded cells to exhibit a more mature electrophysiology as compared to the same neurons cultured in a static culture.

6. The method of claim 5 , wherein said induced neural progenitor cells are derived from induced pluripotent stem cells from a human patient diagnosed with a central nervous system (CNS) disorder.

7. The method of claim 5 , wherein said flow promotes the differentiation of said induced neural progenitor cells.

8. The method of claim 7 , wherein said induced neural progenitor cells differentiate into neurons.

9. The method of claim 8 , wherein said neurons exhibit a more mature electrophysiology in terms of action potential patterns after exposure to said flow as compared to the same neurons cultured in a static culture.

10. The method of claim 5 , wherein said induced neural progenitor cells are derived from induced pluripotent stem cells from a patient diagnosed with Amyotrophic lateral sclerosis (ALS).

11. The method of claim 5 , wherein said brain microvascular endothelial cells are derived from induced pluripotent stem cells from a patient diagnosed with MCT8-specific thyroid hormone cell-membrane transporter deficiency and/or wherein the seeded cells are cultured such that said brain microvascular endothelial cells on said bottom surface form tight junctions.

12. The method of claim 5 , wherein said induced neural progenitor cells were stored frozen and then thawed prior to step c).

13. The method of claim 5 , wherein said more mature electrophysiology comprises one or more features selected from the group consisting of action potential patterns, negative sodium channel current, positive potassium channel current and action potential spikes of amplitude, duration and frequency that are similar to neurons in a physiological environment, or an increased frequency as compared to the same neurons cultured in a static culture.

Assignees

• Emulate Inc
• Cedars Sinai Medical Center

Inventors

• Kerns S Jordan
• Wen Norman
• Lucchesi Carolina
• Hinojosa Christopher David
• Fraser Jacob
• Hamilton Geraldine
• Vatine Gad
• Sances Samuel
• Svendsen Clive
• Levner Daniel
• Sareen Dhruv

Classifications

• C12N2502/088

  neural stem cells · CPC title

• C12N5/0623

  Stem cells · CPC title

• C12N5/0068

  General culture methods using substrates (for specific animal cell type C12N5/06) · CPC title

• B01L2300/123

  Flexible; Elastomeric · CPC title

• B01L2300/0858

  Side walls · CPC title